Literature DB >> 6854209

Enhancement of human eosinophil-mediated killing of Schistosoma mansoni larvae by mononuclear cell products in vitro.

M C Veith, A E Butterworth.   

Abstract

Previous studies have shown that eosinophils from eosinophilic individuals differ functionally from those of normal individuals. In order to test whether agents that might induce eosinophilia could also affect eosinophil function, we have compared the capacity of culture supernatants from mononuclear cells of eosinophilic or normal individuals to enhance eosinophil activity, as reflected by an increased killing of schistosomula of Schistosoma mansoni in vitro. An enhancing activity was detected, which increased both the antibody-dependent, and to some extent the antibody-independent killing of schistosomula by eosinophils, in the absence of complement. Under similar conditions, the supernatants failed to stimulate an otherwise undetectable neutrophil-mediated killing. The activity could be removed from the assay by washing, without reversing previous eosinophil stimulation, and was not directly toxic to the schistosomula. Preliminary characterization of the activity indicated that it was relatively heat-stable at 100 degrees C for 30 min, and had an estimated molecular weight of 35,000-45,000 as judged by G-200 Sephadex fractionation. The activity was produced by a nonlymphocytic, nonspecific esterase-containing adherent mononuclear cell in the absence of either Con A or antigenic stimulation. Significant enhancing activity was detectable after 1 h of culture and continued for at least 25 h. Protein synthesis was required for its production or release. Although the activity was detectable in supernatants from both eosinophilic and normal individuals, the supernatants that demonstrated highest activity and that could be titrated out furthest were generally derived from eosinophilic individuals, suggesting that there might be some association between eosinophilia and enhanced eosinophil function.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6854209      PMCID: PMC2187024          DOI: 10.1084/jem.157.6.1828

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  22 in total

1.  Eosinophils as mediators of antibody-dependent damage to schistosomula.

Authors:  A E Butterworth; R F Sturrock; V Houba; A A Mahmoud; A Sher; P H Rees
Journal:  Nature       Date:  1975-08-28       Impact factor: 49.962

2.  Eosinophils and immune mechanisms. II. Partial characterization of the lymphokine eosinophil stimulation promoter.

Authors:  B M Greene; D G Colley
Journal:  J Immunol       Date:  1974-09       Impact factor: 5.422

3.  Antibody-dependent cell-mediated damage to schistosomula in vitro.

Authors:  A E Butterworth; R F Sturrock; V Houba; P H Rees
Journal:  Nature       Date:  1974-12-06       Impact factor: 49.962

4.  Formation of eosinophilic-like granulocytic colonies by mouse bone marrow cells in vitro.

Authors:  D Metcalf; J Parker; H M Chester; P W Kincade
Journal:  J Cell Physiol       Date:  1974-10       Impact factor: 6.384

5.  The effects of immune rhesus monkey serum on schistosomula of Schistosoma mansoni during cultivation in vitro.

Authors:  J A Clegg; S R Smithers
Journal:  Int J Parasitol       Date:  1972-03       Impact factor: 3.981

6.  Eosinophils and immune mechanisms. Eosinophil stimulation promoter (ESP): a lymphokine induced by specific antigen or phytohemagglutinin.

Authors:  D G Colley
Journal:  J Immunol       Date:  1973-05       Impact factor: 5.422

7.  Identification of the colony-stimulating cell in human peripheral blood.

Authors:  D W Golde; M J Cline
Journal:  J Clin Invest       Date:  1972-11       Impact factor: 14.808

8.  Mechanisms for eosinophilic and neutrophilic leucocytoses.

Authors:  R S Walls; A Basten; E Leuchars; A J Davies
Journal:  Br Med J       Date:  1971-07-17

9.  Lymphoid cell dependence of eosinophil response to antigen. VI. The effect of selective removal of T or B lymphocytes on the capacity of primed spleen cells to adoptively transferred immunity to tetanus toxoid.

Authors:  N M Ponzio; R S Speirs
Journal:  Immunology       Date:  1975-02       Impact factor: 7.397

10.  Mechanism of eosinophilia. II. Role of the lymphocyte.

Authors:  A Basten; P B Beeson
Journal:  J Exp Med       Date:  1970-06-01       Impact factor: 14.307

View more
  20 in total

Review 1.  Eosinophils: a review.

Authors:  B J McEwen
Journal:  Vet Res Commun       Date:  1992       Impact factor: 2.459

2.  The effects of eosinophil activating factor on IgG-dependent sulphidopeptide leukotriene generation by human eosinophils.

Authors:  P Fitzharris; R Moqbel; K J Thorne; B A Richardson; A Hartnell; O Cromwell; A E Butterworth; A B Kay
Journal:  Clin Exp Immunol       Date:  1986-12       Impact factor: 4.330

Review 3.  Eosinophils as effector cells in immunity and hypersensitivity disorders.

Authors:  A B Kay
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

4.  Enhancement of leukotriene C4 release from primate airway macrophages by cellular interactions.

Authors:  A M Campbell; S T Harper; C Hallam; E Wells; J Mann; C Robinson
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

5.  Surface proteins of the human eosinophil. II. Effects of Schistosoma mansoni larvae on eosinophil surface proteins.

Authors:  K J Thorne; B A Richardson; A E Butterworth
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

6.  Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival.

Authors:  A F Lopez; D J Williamson; J R Gamble; C G Begley; J M Harlan; S J Klebanoff; A Waltersdorph; G Wong; S C Clark; M A Vadas
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

7.  Presence of factors chemotactic for granulocytes in hypereosinophilic syndrome sera: relation with alterations in eosinophil migration.

Authors:  P Gosset; L Prin; M Capron; C Auriault; A B Tonnel; A Capron
Journal:  Clin Exp Immunol       Date:  1986-09       Impact factor: 4.330

8.  Plasma membrane antigens on light density and activated human blood eosinophils.

Authors:  P C Tai; D M Bakes; J R Barkans; C J Spry
Journal:  Clin Exp Immunol       Date:  1985-05       Impact factor: 4.330

9.  Hypofibrinogenemia due to fibrin formation in subserosal type eosinophilic gastroenteropathy.

Authors:  E Presterl; L Wagner; W Base
Journal:  Clin Investig       Date:  1992-06

10.  A cellular abnormality in glucocorticoid resistant asthma.

Authors:  M C Poznansky; A C Gordon; I W Grant; A H Wyllie
Journal:  Clin Exp Immunol       Date:  1985-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.